Welsh Biotech Raises £7M for AI-Designed Antibodies
March 2026 — Cardiff, Wales — A Welsh biotechnology startup has secured £7 million in funding to advance the development of antibodies designed using artificial intelligence, aiming to accelerate drug discovery and improve treatment outcomes for a range of diseases. The company, focused on integrating AI with biotechnology, uses machine learning models to predict antibody … Read more